Zydus' Generic Balsalazide Disodium Receives Approval in the U.S.
FDA Confirms Para IV Patent Litigation for Balsalazide Disodium Capsules
Drug firm Lupin has received tentative approval from the US health regulator to market its Balasalazide Disodium tablets, used for treatment of ulcerative colitis, in the American market.
Lupin's Generic Balsalazide Disodium Receives Approval In US